Biomedical startups are racing to revolutionize the way humans reproduce

Biomedical startups are accelerating efforts to commercialize in-vitro gametogenesis (IVG), a process creating human eggs and sperm in a lab from any cellular DNA.

The big picture: Companies are rushing to revolutionize human reproduction and bring IVG techniques to market.
* This groundbreaking technology would allow human eggs and sperm to be made in the lab.

The how: IVG uses any cell in the body containing DNA to manufacture these reproductive cells.
* The process could potentially involve any person’s DNA.

Race to commercialization: Startups in the biomedical field are pushing to be the first to successfully commercialize this technology.
* The commercialization of this technique would mark a pivotal moment in biomedical science and human reproduction.

This article does not provide more detailed information for additional points.

View original article on NPR

This summary was created by an AI system. The use of this summary is subject to our Terms of Service.

Contact us about this post






Leave a Reply

Your email address will not be published. Required fields are marked *